MDM2 and breast carcinoma: While the MDM2 SNP309GG genotype has been associated with a nonsignificantly increased risk for breast cancer, breast cancer patients carrying the SNP309GG genotype have been found particularly sensitive to cancer risk reduction by a second MDM2 SNP (SNP285G>C) 27.